Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXC1HO
|
||||
Drug Name |
Quinoline-3-carboxylic acid [1-(benzyl-methyl-carbamoyl)-2-(1H-indol-3-yl)-ethyl]-amide
|
||||
Synonyms |
CHEMBL324760
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H26N4O2
|
||||
Canonical SMILES |
CN(Cc1ccccc1)C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)c4cnc5ccccc5c4
|
||||
InChI |
InChI=1S/C29H26N4O2/c1-33(19-20-9-3-2-4-10-20)29(35)27(16-22-17-31-26-14-8-6-12-24(22)26)32-28(34)23-15-21-11-5-7-13-25(21)30-18-23/h2-15,17-18,27,31H,16,19H2,1H3,(H,32,34)/t27-/m1/s1
|
||||
InChIKey |
RTZSWSVEJWVMPW-HHHXNRCGSA-N
|
||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1587926] | ||
Cholecystokinin receptor type A | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.